GigaTIME

Microsoft Research and Providence Health introduce GigaTIME, a multimodal AI framework that generates virtual multiplex immunofluorescence (mIF) images from standard H&E pathology slides, enabling population-scale tumor immune microenvironment modeling. The system was applied to over 14,000 cancer patients across 24 cancer types, uncovering over 1,200 statistically significant protein-biomarker associations. - **Cross-modal translation:** GigaTIME learns to translate H&E slides into virtual mIF images across 21 protein channels by training on 40 million cells with paired H&E and mIF data. The model uses a NestedUNet architecture that significantly outperforms CycleGAN baselines on pixel, cell, and slide-level metrics. - **Virtual population at scale:** Applied to 14,256 patients from 51 hospitals across seven US states, generating 299,376 virtual mIF whole-slide images. This enabled discovery of 1,234 statistically significant associations between TIME proteins and clinical biomarkers at pan-cancer, cancer-type, and subtype levels. - **Clinical discovery:** The virtual population revealed associations between immune markers and genomic alterations like TMB-H, MSI-H, and KMT2D mutations. A combined GigaTIME signature of all 21 virtual protein channels outperformed individual markers for patient stratification and survival prediction. - **Combinatorial insights:** Analysis found that combining protein channels like CD138 and CD68 yields stronger biomarker associations than either protein alone, suggesting coordinated immune responses in antibody-mediated tumor mechanisms. - **Independent validation:** Testing on 10,200 TCGA patients showed strong concordance with Providence results (Spearman correlation 0.88), demonstrating GigaTIME's generalizability across different patient populations and data sources.